$44.40
-0.09-0.2%
Last update: Nov 6, 6:11 PM
Liquidia Corp (LQDA) Stock Price, Quote, News & History
LQDANASDAQ
Liquidia (LQDA) stock jumped 40% after settling all lawsuit battles with United Therapeutics for $380.7M. YUTREPIA PAH sales continue.
You can purchase shares of Liquidia (NASDAQ:LQDA) through any online brokerage.
Other companies in Liquidia’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Liquidia has a consensus price target of $42.81.
The stock price for Liquidia (NASDAQ: LQDA) is $44.2418 last updated November 6, 2026 at 6:11 PM EST.
There are no upcoming dividends for Liquidia.
Liquidia does not have any upcoming earnings scheduled.
There is no upcoming split for Liquidia.
Liquidia is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary...
